Who should be careful
341 of 15/03/2022 of Italian Ministry of University and Research funded by the European UnionNext Generation EU Award Number: Project code PE0000003, Concession Decree No
Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies
Albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, orforglipron and semaglutide used in the clinic are monoGLP-1RAs, tirzepatide acts not only on GLP1R, but also on glucose-dependent receptors of insulinotropic peptide (GIP), and retatrutide is a triple agonist of GLP-1, GIP and glucagon receptors
Key Points Wegovy is a self-administered, once-weekly injection that comes in a pre-filled, single-dose pen